Jul 18, 2018
Trial Adds Gemcitabine to Pleural Mesothelioma HIOC Therapy
New on www.DailyBrian.com
http://bit.ly/2zONDSB
Trial Adds Gemcitabine to Pleural Mesothelioma HIOC Therapy
Results of a phase I clinical trial highlight how the addition of a drug to an existing treatment option appears safe and may improve outcomes in certain patients with malignant pleural mesothelioma (MPM). The primary goal of the trial was to determine the maximum tolerated dose of gemcitabine......